Furthermore, an analysis of data from the Cancer Genome Atlas (TCGA) has revealed that high-Treg CRCs exhibit enrichment in several pro-cancer signaling pathways compared to low-Treg CRCs, including EMT, Kras, Hypoxia, TGF-β, TNF-α, and angiogenesis. This evidence concerns the gene KRAS and cancer.